PHARMOS CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2010-09-03: Form 8-K; Period of report 2010-09-02; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; Details 5.02.
- 2010-02-02: Form 8-K; Period of report 2010-01-27; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2010-09-03 | 8-K | 2010-09-02 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 On September 2, 2010, the Board of Directors of Pharmos Corporation appointed Dr. Steven Leventer to the company’s Board, effective September 3, 2010. 8.01 On September 2, 2010, the Board of Directors of Pharmos Corporation adopted a change in the company’s Director compensation policy. | currentreport.htm |
| 2010-02-02 | 8-K | 2010-01-27 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On January 27, 2010, the Compensation and Stock Option Committee of the Board of Directors of Pharmos Corporation, taking into account that no bonuses were awarded for 2008, approved the following cash bonuses for 2009 performance: $80,000 for each of Robert F. Johnston, the company’s Executive Chairman, and S. Colin Neill, the company’s President and Chief Financial Officer. | currentreport.htm |